Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Br J Surg ; 100(13): 1689-700, 2013 Dec.
Article in English | MEDLINE | ID: mdl-24227353

ABSTRACT

BACKGROUND: Vascular clamping reduces blood loss during liver resection but leads to ischaemia-reperfusion injury. Ischaemic preconditioning (IP) may reduce this. This study aimed to evaluate IP in liver resection under clamping. METHODS: This was a systematic review and meta-analysis of randomized clinical trials (RCTs) evaluating IP in adults undergoing liver resection under either continuous clamping (CC) or intermittent clamping (IC). Primary outcomes were mortality, liver failure and morbidity. Secondary outcomes included duration of operation, blood loss, length of hospital stay, length of intensive therapy unit stay, transfusion requirements, prothrombin time, and bilirubin and aminotransferase levels. Weighted mean differences were calculated for continuous data, and pooled odds ratios (ORs) for dichotomous data. Results were produced with a random-effects model with 95 per cent confidence intervals (c.i.). RESULTS: A total of 2960 records were identified and 11 RCTs included 669 patients (IP 331, control 338). No significant difference in mortality (6 RCTs; IP 186, control 190; OR 1·36, 95 per cent c.i. 0·13 to 13·68; P = 0·80) or morbidity (6 RCTs; IP 186, control 190; OR 0·58, 0·31 to 1·07; P = 0·08) was found for IP plus CC versus CC. Nor was there a significant difference in mortality (4 RCTs; IP 122, control 121; OR 1·33, 0·24 to 7·32; P = 0·74) or morbidity (4 RCTs; IP 122, control 121; OR 0·87, 0·52 to 1·47; P = 0·61) for IP plus (CC or IC) versus IC. No significant differences were found for secondary outcome measures. CONCLUSION: This meta-analysis failed to find a significant benefit of IP in liver resection.


Subject(s)
Hepatectomy/methods , Ischemic Preconditioning/methods , Reperfusion Injury/prevention & control , Adult , Alanine Transaminase/blood , Aspartate Aminotransferases/blood , Bilirubin/blood , Blood Loss, Surgical/statistics & numerical data , Blood Transfusion/mortality , Blood Transfusion/statistics & numerical data , Constriction , Hepatectomy/mortality , Humans , Ischemic Preconditioning/mortality , Length of Stay/statistics & numerical data , Liver Failure/etiology , Liver Failure/mortality , Operative Time , Postoperative Complications/etiology , Postoperative Complications/mortality , Prothrombin Time/statistics & numerical data , Randomized Controlled Trials as Topic , Reperfusion Injury/mortality , Treatment Outcome
2.
Dig Surg ; 30(4-6): 337-47, 2013.
Article in English | MEDLINE | ID: mdl-24051581

ABSTRACT

Half of all patients with colorectal cancer develop metastatic disease. The liver is the principal site for metastases, and surgical resection is the only modality that offers the potential for long-term cure. Appropriate patient selection for surgery and improvements in perioperative care have resulted in low morbidity and mortality rates, resulting in this being the therapy of choice for suitable patients. Modern management of colorectal liver metastases is multimodal incorporating open and laparoscopic surgery, ablative therapies such as radiofrequency ablation or microwave ablation and (neo)adjuvant chemotherapy. The majority of patients with hepatic metastases should be considered for resectional surgery, if all disease can be resected, as this offers the only opportunity for prolonged survival.


Subject(s)
Colorectal Neoplasms/pathology , Hepatectomy/methods , Liver Neoplasms/secondary , Liver Neoplasms/surgery , Biopsy , Colorectal Neoplasms/mortality , Colorectal Neoplasms/surgery , Diagnostic Imaging/methods , Humans , Liver Neoplasms/diagnosis , Liver Neoplasms/mortality , Liver Neoplasms/pathology , Lung Neoplasms/secondary , Lymphatic Metastasis , Neoplasm Recurrence, Local/surgery , Neoplasm Staging , Preoperative Care , Survival Analysis
3.
Scott Med J ; 56(4): 223-6, 2011 Nov.
Article in English | MEDLINE | ID: mdl-22089045

ABSTRACT

The Scottish Liver Transplant Unit (SLTU) opened in 1992 and has now performed over 900 liver transplants. During this time there have been major changes in both organ donation and transplantation. Currently liver transplantation is restricted by limited organ supply. Scotland has one of the lowest rates of organ donation in Europe and one of the most rapidly increasing rates of cirrhosis. The consequent waiting list mortality has driven innovations including increasing use of marginal grafts, organs donated after cardiac death, split-liver transplants and the development of living-donor liver transplantation. To maintain liver transplantation, there is an urgent need to increase organ donation rates and to find novel treatments which optimize outcomes from marginal grafts. This review addresses the surgical aspects of liver transplantation and how these have evolved over the two past decades. Major changes are currently underway in organ donation organization, and there is continuing refinement of organ treatment and storage. A number of measures to maintain and improve organ preservation and function are currently being evaluated in clinical trials, and cell therapy holds significant potential for the future. Scotland has a rising need for liver transplantation and the SLTU continues to provide high-quality care and to be at the forefront of the latest advances in organ transplantation.


Subject(s)
Liver Transplantation/trends , Tissue and Organ Procurement/trends , Humans , Liver Transplantation/methods , Scotland , Tissue Donors/statistics & numerical data , Tissue and Organ Harvesting/methods , Tissue and Organ Harvesting/trends , Tissue and Organ Procurement/methods , Tissue and Organ Procurement/organization & administration
4.
Scott Med J ; 54(3): 22-4, 2009 Aug.
Article in English | MEDLINE | ID: mdl-19725278

ABSTRACT

The Surviving Sepsis Campaign (SSC) recommends Early Goal Directed Therapy (EGDT) in the treatment of septic shock, which requires key critical care skills and knowledge. This study evaluates the availability of these skills in Specialist Registrars in acute hospital specialities in the UK. A questionnaire was sent to Specialist Registrars in Anaesthetics, General Surgery and General Medicine throughout Scotland. One hundred and eighty five responses were obtained. One hundred percent of anaesthetists, 70% of surgeons and 51% of physicians were aware of EGDT Only 62 trainees (6% of surgeons, 79% of anaesthetists, 19% of physicians) had the full complement of skills and knowledge to implement EGDT. This study demonstrates that non-anaesthetic registrars in the UK lack both knowledge and skills required to provide EGDT. The main deficit was in awareness, demonstrating that knowledge of EGDT is not penetrating into specialities beyond anaesthesia. It is now time for the SSC to specifically target non-anaesthetic specialities.


Subject(s)
Anesthesiology , Clinical Competence , Critical Care , Family Practice , General Surgery , Shock, Septic/therapy , Cardiovascular Agents/therapeutic use , Catheterization , Health Care Surveys , Humans , Medical Staff, Hospital/education , Needs Assessment , Scotland
5.
J Med Ethics ; 31(11): 631-4, 2005 Nov.
Article in English | MEDLINE | ID: mdl-16269556

ABSTRACT

The shortage of organs for transplantation has led researchers to look for new techniques to expand the donor pool. Preconditioning strategies have the potential to protect organs from transplant associated injury or may improve the function of substandard organs so that they become suitable for transplantation. Translating this type of technology to the clinical setting raises ethical issues, particularly relating to the deceased donor. It is important that society has the opportunity to discuss the issues raised by implementation of preconditioning strategies before they are implemented rather than as a reaction to them.


Subject(s)
Tissue and Organ Procurement/ethics , Transplantation/ethics , Bioethical Issues , Graft Survival/ethics , Humans , Living Donors/ethics , Patient Selection/ethics , Tissue Donors/ethics , Tissue and Organ Procurement/methods , Transplantation/methods
SELECTION OF CITATIONS
SEARCH DETAIL
...